MRDC Prepares High-Throughput Infectious Disease Screening Technology for Commercialization
The Biodefense Mass Sequencing and Surveillance assay, developed by the Synthetic Biology and Biosurveillance Branch at the U.S. Army Medical Research Institute of Infectious Diseases, combines off-the-shelf polymerase chain reaction instruments with large-scale sample pooling and retooled next-generation DNA sequencing assays to rapidly screen samples to identify infected patients and reduce the risk of disease outbreaks.
